Potential for dose-escalation and reduction of risk in pancreatic cancer using IMRT optimization with lexicographic ordering and gEUD-based cost functions

Medical Physics

Volumn 34, Issue 2, 2007, Pages 521-529

  Spalding, Aaron C ^a   Jee, Kyung Wook ^a   Vineberg, Karen ^a   Jablonowski, Marla ^a   Fraass, Benedick A ^a   Pan, Charlie C ^a   Lawrence, Theodore S ^a   Ten Haken, Randall K ^a   Ben Josef, Edgar ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Equivalent uniform dose; Intensity modulated radiation therapy; Lexicographic ordering; Pancreatic cancer

Indexed keywords

COST FUNCTIONS; COST REDUCTION; DISEASES; SURGERY; TUMORS;

CONCOMITANT REDUCTION; EQUIVALENT UNIFORM DOSE; GENERALIZED EQUIVALENT UNIFORM DOSE (GEUD); HIERARCHICAL OPTIMIZATION; INTENSITY MODULATED RADIATION THERAPY; LEXICOGRAPHIC ORDER; PANCREATIC CANCERS; PLANNING TARGET VOLUMES;

RADIOTHERAPY;

ADVANCED CANCER; ARTICLE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; PANCREAS CANCER; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RISK REDUCTION; TREATMENT OUTCOME; TREATMENT PLANNING;

PERU TOMATO MOSAIC VIRUS;

EID: 33846573270     PISSN: 00942405     EISSN: None     Source Type: Journal    
DOI: 10.1118/1.2426403     Document Type: Article

References (58)

1. A. Jemal, T. Murray, E. Ward, A. Samuels, R. C. Tiwari, A. Ghafoor, E. J. Feuer, and M. J. Thun, " Cancer statistics, 2005., " Ca-Cancer J. Clin. 55, 10-30 (2005).
2. " Treatment of locally unresectable carcinoma of the pancreas: Comparison of combined-modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. Gastrointestinal Tumor Study Group., " J. Natl. Cancer Inst. 80, 751-755 (1988).
3. D. Li, K. Xie, R. Wolff, and J. L. Abbruzzese, " Pancreatic cancer., " Lancet 363, 1049-1057 (2004).
4. R. J. Geer and M. F. Brennan, " Prognostic indicators for survival after resection of pancreatic adenocarcinoma., " Am. J. Surg. 165, 68-72; discussion 72-63 (1993).
5. G. E. Roldan, L. L. Gunderson, D. M. Nagorney, J. K. Martin, D. M. Ilstrup, M. A. Holbrook, L. K. Kvols, and D. C. McIlrath, " External beam versus intraoperative and external beam irradiation for locally advanced pancreatic cancer., " Cancer 61, 1110-1116 (1988).
6. C. G. Moertel, S. Frytak, R. G. Hahn, M. J. O'Connell, R. J. Reitemeier, J. Rubin, A. J. Schutt, L. H. Weiland, D. S. Childs, M. A. Holbrook, P. T. Lavin, E. Livstone, H. Spiro, A. Knowlton, M. Kalser, J. Barkin, H. Lessner, R. Mann-Kaplan, K. Ramming, H. O. Douglas, Jr., P. Thomas, H. Nave, J. Bateman, J. Lokich, J. Brooks, J. Chaffey, J. M. Corson, N. Zamcheck, and J. W. Novak, " Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads+5-fluorouracil), and high dose radiation + 5-fluorouracil: The Gastrointestinal Tumor Study Group., " Cancer 48, 1705-1710 (1981).
7. D. J. Klaassen, J. M. MacIntyre, G. E. Catton, P. F. Engstrom, and C. G. Moertel, " Treatment of locally unresectable cancer of the stomach and pancreas: A randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil-an Eastern Cooperative Oncology Group study., " J. Clin. Oncol. 3, 373-378 (1985).
8. R. R. Dobelbower, Jr., H. W. Merrick, 3rd, R. K. Ahuja, and R. T. Skeel, " 125I interstitial implant, precision high-dose external beam therapy, and 5-FU for unresectable adenocarcinoma of pancreas and extrahepatic biliary tree., " Cancer 58, 2185-2195 (1986).
9. M. Mohiuddin, F. Rosato, D. Barbot, A. Schuricht, W. Biermann, and R. Cantor, " Long-term results of combined modality treatment with I-125 implantation for carcinoma of the pancreas., " Int. J. Radiat. Oncol., Biol., Phys. 23, 305-311 (1992).
10. M. Mohiuddin, W. F. Regine, J. Stevens, F. Rosato, D. Barbot, W. Biermann, and R. Cantor, " Combined intraoperative radiation and perioperative chemotherapy for unresectable cancers of the pancreas., " J. Clin. Oncol. 13, 2764-2768 (1995).
11. H. M. Ceha, G. van Tienhoven, D. J. Gouma, C. H. Veenhof, C. J. Schneider, E. A. Rauws, S. S. Phoa, and D. Gonzalez Gonzalez, " Feasibility and efficacy of high dose conformal radiotherapy for patients with locally advanced pancreatic carcinoma., " Cancer 89, 2222-2229 (2000).
12. S. Jain, M. Sacchi, P. Vrachnos, and N. J. Lygidakis, " Carcinoma of the pancreas with portal vein involvement-our experience with a modified technique of resection., " Hepato-Gastroenterology 52, 1596-1600 (2005).
13. N. J. Lygidakis, G. Singh, E. Bardaxoglou, G. Dedemadi, G. Sgourakis, J. Nestoridis, A. Malliotakis, M. Pedonomou, E. K. Solomou, M. Safioleas, M. Alamani, L. Grigorakos, and E. M. Merikas, " Mono-bloc total spleno-pancreaticoduodenectomy for pancreatic head carcinoma with portal-mesenteric venous invasion. A prospective randomized study., " Hepato-Gastroenterology 51, 427-433 (2004).
14. M. Schwarz, M. Alber, J. V. Lebesque, B. J. Mijnheer, and E. M. Damen, " Dose heterogeneity in the target volume and intensity-modulated radiotherapy to escalate the dose in the treatment of non-small-cell lung cancer., " Int. J. Radiat. Oncol., Biol., Phys. 62, 561-570 (2005).
15. B. Choi and J. O. Deasy, " The generalized equivalent uniform dose function as a basis for intensity-modulated treatment planning., " Phys. Med. Biol. 47, 3579-3589 (2002).
16. A. Niemierko, " A generalized concept of equivalent uniform dose (EUD) [Abstract]., " Med. Phys. 26, 1100 (1999).
17. C. Thieke, T. Bortfeld, A. Niemierko, and S. Nill, " From physical dose constraints to equivalent uniform dose constraints in inverse radiotherapy planning., " Med. Phys. 30, 2332-2339 (2003).
18. E. Thomas, O. Chapet, M. L. Kessler, T. S. Lawrence, and R. K. Ten Haken, " Benefit of using biologic parameters (EUD and NTCP) in IMRT optimization for treatment of intrahepatic tumors., " Int. J. Radiat. Oncol., Biol., Phys. 62, 571-578 (2005).
19. Q. Wu, R. Mohan, A. Niemierko, and R. Schmidt-Ullrich, " Optimization of intensity-modulated radiotherapy plans based on the equivalent uniform dose., " Int. J. Radiat. Oncol., Biol., Phys. 52, 224-235 (2002).
20. O. Chapet, E. Thomas, M. L. Kessler, B. A. Fraass, and R. K. Ten Haken, " Esophagus sparing with IMRT in lung tumor irradiation: An EUD-based optimization technique., " Int. J. Radiat. Oncol., Biol., Phys. 63, 179-187 (2005).
21. C. Cotrutz, M. Lahanas, C. Kappas, and D. Baltas, " A multiobjective gradient-based dose optimization algorithm for external beam conformal radiotherapy., " Phys. Med. Biol. 46, 2161-2175 (2001).
22. E. Schreibmann, M. Lahanas, L. Xing, and D. Baltas, " Multiobjective evolutionary optimization of the number of beams, their orientations and weights for intensity-modulated radiation therapy., " Phys. Med. Biol. 49, 747-770 (2004).
23. K. Miettinen, Nonlinear Multiobjective Optimization (Kluwer, Boston, 1999).
24. C. J. McGinn, M. M. Zalupski, I. Shureiqi, J. M. Robertson, F. E. Eckhauser, D. C. Smith, D. Brown, G. Hejna, M. Strawderman, D. Normolle, and T. S. Lawrence, " Phase I trial of radiation dose escalation with concurrent weekly full-dose gemcitabine in patients with advanced pancreatic cancer., " J. Clin. Oncol. 19, 4202-4208 (2001).
25. E. Ben-Josef, A. F. Shields, U. Vaishampayan, V. Vaitkevicius, B. F. El-Rayes, P. McDermott, J. Burmeister, T. Bossenberger, and P. A. Philip, " Intensity-modulated radiotherapy (IMRT) and concurrent capecitabine for pancreatic cancer., " Int. J. Radiat. Oncol., Biol., Phys. 59, 454-459 (2004).
26. K.-W. Jee, D. L. McShan, and B. A. Fraass, " Intuitive Multicriteria IMRT Optimization Using a Lexicographic Approach [Abstract]., " Med. Phys. 31, 1715 (2004).
27. K. Jee, B. Fraass and D. McShan, " Implementation of automatic differentiation tools for multicriteria IMRT optimization., " in Automatic Differentiation: Applications, Theory, and Tools, Lecture Notes in Computational Science and Engineering 50 (Springer, 2005), pp. 225-234.
28. K.-W. Jee, D. L. McShan, K. A. Vineberg, and B. A. Fraass, " Performance Evaluations of a Preemptive Approach in IMRT Planning [Abstract]., " Med. Phys. 33, 2128 (2006).
29. M. Kessler, D. McShan, and K. Vineberg, " Costlets: A generalized approach to cost functions for automated optimization., " Optim. Eng. 6, 421-448 (2005).
30. J. T. Lyman, " Complication probability as assessed from dose-volume histograms., " Radiat. Res. Suppl. 8, S13-19 (1985).
31. J. Nocedal and S. Wright, Numerical Optimization (Springer, New York, 1999).
32. T. Bortfeld, J. Stein, and K. Preiser, " Clinically relevant intensity modulation optimization using physical criteria., " Proceedings of the XII International Conference on the Use of Computers in Radiation Therapy, edited by, G. Starkschall, and, D. D. Leavitt, (Advanced Medical Publishing, Madison, WI, 1997), pp. 1-4.
33. Q. Wu and R. Mohan, " Algorithms and functionality of an intensity modulated radiotherapy optimization system., " Med. Phys. 27, 701-711 (2000).
34. P. Gill, W. Murray, and M. Saunders, " SNOPT: An SQP algorithm for large-scale constrained optimization., " SIAM J. Optim. 12, 979-1006 (2002).
35. J. Lian and L. Xing, " Incorporating model parameter uncertainty into inverse treatment planning., " Med. Phys. 31, 2711-2720 (2004).
36. X. A. Li, J. Z. Wang, P. A. Jursinic, C. A. Lawton, and D. Wang, " Dosimetric advantages of IMRT simultaneous integrated boost for high-risk prostate cancer., " Int. J. Radiat. Oncol., Biol., Phys. 61, 1251-1257 (2005).
37. R. K. Ten Haken, T. S. Lawrence, D. L. McShan, R. J. Tesser, B. A. Fraass, and A. S. Lichter, " Technical considerations in the use of 3-D beam arrangements in the abdomen., " Radiother. Oncol. 22, 19-28 (1991).
38. J. M. Robertson, L. Marsh, R. K. Ten Haken, and T. S. Lawrence, " The clinical application of a non-axial treatment plan for pancreatic and biliary malignancies., " Radiother. Oncol. 24, 198-200 (1992).
39. M. Schwarz, J. V. Lebesque, B. J. Mijnheer, and E. M. Damen, " Sensitivity of treatment plan optimisation for prostate cancer using the equivalent uniform dose (EUD) with respect to the rectal wall volume parameter., " Radiother. Oncol. 73, 209-218 (2004).
40. T. Rancati, C. Fiorino, G. Gagliardi, G. M. Cattaneo, G. Sanguineti, V. C. Borca, C. Cozzarini, G. Fellin, F. Foppiano, G. Girelli, L. Menegotti, A. Piazzolla, V. Vavassori, and R. Valdagni, " Fitting late rectal bleeding data using different NTCP models: Results from an Italian multi-centric study (AIROPROS0101)., " Radiother. Oncol. 73, 21-32 (2004).
41. M. Ghilezan, D. Yan, J. Liang, D. Jaffray, J. Wong, and A. Martinez, " Online image-guided intensity-modulated radiotherapy for prostate cancer: How much improvement can we expect? A theoretical assessment of clinical benefits and potential dose escalation by improving precision and accuracy of radiation delivery., " Int. J. Radiat. Oncol., Biol., Phys. 60, 1602-1610 (2004).
42. W. A. Tome and J. F. Fowler, " Selective boosting of tumor subvolumes., " Int. J. Radiat. Oncol., Biol., Phys. 48, 593-599 (2000).
43. J. O. Deasy, " Partial tumor boosts: Even more attractive than theory predicts?, " Int. J. Radiat. Oncol., Biol., Phys. 51, 279-280 (2001).
44. M. T. Milano, S. J. Chmura, M. C. Garofalo, C. Rash, J. C. Roeske, P. P. Connell, O. H. Kwon, A. B. Jani, and R. Heimann, " Intensity-modulated radiotherapy in treatment of pancreatic and bile duct malignancies: Toxicity and clinical outcome., " Int. J. Radiat. Oncol., Biol., Phys. 59, 445-453 (2004).
45. M. Tsujie, S. Nakamori, E. Tanaka, H. Nagano, K. Umeshita, K. Dono, M. Sakon, T. Inoue, T. Inoue, and M. Monden, " Phase I/II trial of hyperfractionated accelerated chemoradiotherapy for unresectable advanced pancreatic cancer., " Jpn. J. Clin. Oncol. 36, 504-510 (2006).
46. F. B. Zimmermann, C. Schuhmacher, C. Lersch, B. Bernhardt, P. Pickel, J. R. Siewert, M. Molls, and B. Jeremic, " Sequential and/or concurrent hypofractionated radiotherapy and concurrent chemotherapy in neoadjuvant treatment of advanced adenocarcinoma of the pancreas. Outcome and patterns of failure., " Hepato-Gastroenterology 51, 1842-1846 (2004).
47. M. Hoyer, H. Roed, L. Sengelov, A. Traberg, L. Ohlhuis, J. Pedersen, H. Nellemann, A. Kiil Berthelsen, F. Eberholst, S. A. Engelholm, and H. von der Maase, " Phase-II study on stereotactic radiotherapy of locally advanced pancreatic carcinoma., " Radiother. Oncol. 76, 48-53 (2005).
48. T. Rich, J. Harris, R. Abrams, B. Erickson, M. Doherty, J. Paradelo, W. Small, Jr., H. Safran, and H. J. Wanebo, " Phase II study of external irradiation and weekly paclitaxel for nonmetastatic unresectable pancreatic cancer: RTOG-98-12., " Am. J. Clin. Oncol. 27, 51-56 (2004).
49. E. Horst, O. Micke, C. Moustakis, A. Schuck, U. Schafer, and N. A. Willich, " Conformal therapy for pancreatic cancer: Variation of organ position due to gastrointestinal distention-implications for treatment planning., " Radiology 222, 681-686 (2002).
50. D. P. Gierga, G. T. Chen, J. H. Kung, M. Betke, J. Lombardi, and C. G. Willett, " Quantification of respiration-induced abdominal tumor motion and its impact on IMRT dose distributions., " Int. J. Radiat. Oncol., Biol., Phys. 58, 1584-1595 (2004).
51. Y. C. Ahn, S. Shimizu, H. Shirato, T. Hashimoto, Y. Osaka, X. Q. Zhang, T. Abe, M. Hosokawa, and K. Miyasaka, " Application of real-time tumor-tracking and gated radiotherapy system for unresectable pancreatic cancer., " Yonsei Med. J. 45, 584-590 (2004).
52. L. A. Dawson, K. K. Brock, S. Kazanjian, D. Fitch, C. J. McGinn, T. S. Lawrence, R. K. Ten Haken, and J. Balter, " The reproducibility of organ position using active breathing control (ABC) during liver radiotherapy., " Int. J. Radiat. Oncol., Biol., Phys. 51, 1410-1421 (2001).
53. M. Fuss, B. J. Salter, S. X. Cavanaugh, C. Fuss, A. Sadeghi, C. D. Fuller, A. Ameduri, J. M. Hevezi, T. S. Herman, and C. R. Thomas, Jr., " Daily ultrasound-based image-guided targeting for radiotherapy of upper abdominal malignancies., " Int. J. Radiat. Oncol., Biol., Phys. 59, 1245-1256 (2004).
54. T. Hashimoto, H. Shirato, M. Kato, K. Yamazaki, N. Kurauchi, T. Morikawa, S. Shimizu, Y. C. Ahn, Y. Akine, and K. Miyasaka, " Real-time monitoring of a digestive tract marker to reduce adverse effects of moving organs at risk (OAR) in radiotherapy for thoracic and abdominal tumors., " Int. J. Radiat. Oncol., Biol., Phys. 61, 1559-1564 (2005).
55. R. J. Bold, C. Charnsangavej, K. R. Cleary, M. Jennings, A. Madray, S. D. Leach, J. L. Abbruzzese, P. W. Pisters, J. E. Lee, and D. B. Evans, " Major vascular resection as part of pancreaticoduodenectomy for cancer: Radiologic, intraoperative, and pathologic analysis., " J. Gastrointest Surg. 3, 233-243 (1999).
56. J. B. Ammori, L. M. Colletti, M. M. Zalupski, F. E. Eckhauser, J. K. Greenson, J. Dimick, T. S. Lawrence, and C. J. McGinn, " Surgical resection following radiation therapy with concurrent gemcitabine in patients with previously unresectable adenocarcinoma of the pancreas., " J. Gastrointest Surg. 7, 766-772 (2003).
57. A. Sa Cunha, A. Rault, C. Laurent, X. Adhoute, V. Vendrely, G. Bellannee, R. Brunet, D. Collet, and B. Masson, " Surgical resection after radiochemotherapy in patients with unresectable adenocarcinoma of the pancreas., " J. Am. Coll. Surg. 201, 359-365 (2005).
58. M. Machtay, D. I. Rosenthal, A. A. Chalian, R. Lustig, D. Hershock, L. Miller, G. S. Weinstein, and R. S. Weber, " Pilot study of postoperative reirradiation, chemotherapy, and amifostine after surgical salvage for recurrent head-and-neck cancer., " Int. J. Radiat. Oncol., Biol., Phys. 59, 72-77 (2004).